ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

Position in HRMY — Harmony Biosciences Holdings, Inc.

CIK 1164508 BOSTON, MA

Position in HRMY

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$47,789,945

+$9,076,960 QoQ

Shares Held

1,312,550

-5.0% QoQ

Ownership

2.25%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#11

of 328 holders

Holding Since

Mar 2021

9 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Healthcare · as of Jun 30, 2026

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $2,519,535,758 across 72 Biotechnology names. HRMY ranks #14 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	738,378	$366,774,503
2	INCY	Incyte Corp	2,744,958	$311,168,438
3	REGN	Regeneron Pharmaceuticals, Inc.	393,685	$245,478,344
4	EXEL	Exelixis, Inc.	4,365,926	$237,550,033
5	GMAB	Genmab A/S	4,975,324	$136,672,150
6	RPRX	Royalty Pharma plc	2,435,341	$136,549,569
7	HALO	Halozyme Therapeutics, Inc.	1,704,623	$133,420,842
8	ONC	BeOne Medicines Ltd.	249,758	$71,173,537

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$47,789,945	1,312,550	-5.0%	Shares	Defined	2026-08-13
2026-03-31	$38,712,985	1,382,113	-7.3%	Shares	Defined	2026-05-14
2025-12-31	$55,815,859	1,491,605	+15.1%	Shares	Defined	2026-02-13
2025-09-30	$35,700,700	1,295,381	+42.8%	Shares	Defined	2025-11-13
2025-06-30	$28,658,324	906,909	+127.6%	Shares	Defined	2025-08-13
2025-03-31	$13,223,261	398,411	+34.3%	Shares	Defined	2025-05-14
2024-12-31	$10,206,625	296,618	-6.6%	Shares	Defined	2025-02-12
2024-09-30	$12,702,640	317,566	+1753.4%	Shares	Defined	2024-11-14
2021-03-31	$566,107	17,134	—	Shares	Defined	2021-05-14
No filing history on record for this holder in this stock.